Best Metastatic Tnbc Podcasts (2024)

1
T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy 19:57

2M ago19:57

19:57

Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD. Related Content: T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

1
Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time 25:53

3M ago25:53

25:53

Interview with Tobias Janowitz, MD, PhD, and Karen Winkfield, MD, PhD, authors of Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time. Hosted by Vivek Subbiah, MD. Related Content: Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time…

1
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer 14:26

4M ago14:26

14:26

Interview with José P. Leone, MD, author of Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. Hosted by Nora L. (Mary) Disis, MD. Related Content: Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

1
Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US 17:31

6M ago17:31

17:31

Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD. Related Content: Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

1
Atezolizumab in Combination With Carboplatin in Metastatic TNBC 18:18

6M ago18:18

18:18

Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial. Hosted by Mary L. (Nora) Disis, MD. Related Content: Atezolizumab in …

1
Updates in the Treatment of Patients with EGFR Exon 20 Insertion Mutation NSCLC 10:17

7M ago10:17

10:17

This podcast provides an overview of current and emerging data available in the treatment of EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer, including updates from ESMO 2023. Key takeaways:- Review treatment options for EGFR Exon 20 Insertion Mutations in NSCLC - Review updated clinical data from ELCC and ESMO 2023 - Gain an understandi…

1
Shorter-Course Radiotherapy for Prostate Cancer 15:14

9M ago15:14

15:14

Interview with Daniel E. Spratt, MD, author of Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer. Hosted by Jack West, MD. Related Content: Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer

1
Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer 19:02

9M ago19:02

19:02

Interview with Oreste Davide Gentilini, MD, author of Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients Wit…

1
A Geospatial Analysis of Disparities in Access to Oncofertility Services 23:12

11M ago23:12

23:12

Interview with Kara N. Goldman, MD, author of A Geospatial Analysis of Disparities in Access to Oncofertility Services. Hosted by Jack West, MD. Related Content: A Geospatial Analysis of Disparities in Access to Oncofertility Services

1
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases 16:29

11M ago16:29

16:29

Interview with Sean P. Pitroda, MD, author of Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Integrated Clinical-Molecular Classification of Colorectal Liver Metastases…

1
US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020 17:16

12M ago17:16

17:16

Interview with Sophia C. Kamran, MD, author of US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020. Hosted by Jack West, MD. Related Content: US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020

1
Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer 15:07

1y ago15:07

15:07

Interview with Robert W. Holloway, MD, and Sarfraz Ahmad, PhD, authors of Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial. Hosted by Jack West, MD. Related Content: Clinical Activi…

1
Radiosurgery of Spine Metastasis—NRG/RTOG 0631 RCT Final Results 14:15

1y ago14:15

14:15

Interview with Samuel Ryu, MD, author of Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of t…

1
Pathologic Complete Response and Clinical Outcomes in Soft Tissue Sarcoma 14:03

1y ago14:03

14:03

Interview with Dian Wang, MD, author of Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials. Hosted by Jack West, MD. Related Content: Pathologic Complete Response and Clinical Outcomes i…

1
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma 16:40

1+ y ago16:40

16:40

Interview with Laura A. Bolte, MSc, Geke A. P. Hospers, MD, PhD, and Rinse K. Weersma, MD, PhD, authors of Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma. Hosted by Jack West, MD. Related Content: Association of a Mediterranean Diet With Outcomes for Patients Treated With…

1
Adoption of Innovative Therapies Across Oncology Practices 21:08

1+ y ago21:08

21:08

Interview with Nancy L. Keating, MD, MPH, author of Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy. Hosted by Jack West, MD. Related Content: Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy

1
Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy 18:37

1+ y ago18:37

18:37

Interview with Marco Del Chiaro, MD, PhD, author of Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Hosted by Jack West, MD. Related Content: Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemot…

1
Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma 18:28

1+ y ago18:28

18:28

Interview with Linda M. Liau, MD, PhD, author of Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. Hosted by Jack West, MD. Related Content: Association of Autologous Tumor Lysat…

1
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma 12:16

1+ y ago12:16

12:16

Interview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma. Hosted by Jack West, MD. Related Content: Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma…

1
Prostate-Specific Antigen Screening Rates and Metastatic Prostate Cancer Incidence in the VHA 16:36

1+ y ago16:36

16:36

Interview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. Hosted by Jack West, MD. Related Content: Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incid…

1
Therapy and Survival Patterns in Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy 15:26

2y ago15:26

15:26

Interview with Hagen F. Kennecke, MD, author of Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy. Hosted by Jack West, MD.

1
Global Association of COVID-19 Pandemic Measures With Cancer Screening 12:53

2y ago12:53

12:53

Interview with Paolo Boffetta, MD, author of Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis. Hosted by Jack West, MD.

1
A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief 22:07

2y ago22:07

22:07

In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public he…

1
High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade 19:09

2y ago19:09

19:09

Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Hosted by Jack West, MD.

1
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality 14:06

2y ago14:06

14:06

Interview with Lars Björnebo, MSc, and Anna Lantz, MD, PhD, authors of Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality. Hosted by Jack West, MD.

1
Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma 23:31

2y ago23:31

23:31

Interview with David Anthony Palma, MD, PhD, and Anthony C. Nichols, MD, authors of Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial Hosted by Jack West, MD.…

1
Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer 20:09

2+ y ago20:09

20:09

Interview with Kenneth L. Kehl, MD, MPH, author of Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216). Hosted by Jack West, MD.

1
Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer 15:22

2+ y ago15:22

15:22

Interview with Ruth C. Carlos, MD and Gelareh Sadigh, MD, authors of Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial. Hosted by Jack West, MD.…

1
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy 18:16

2+ y ago18:16

18:16

Interview with Laurent Dercle, MD, PhD, author of Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis. Hosted by Jack West, MD.

1
Fork Cancer! Episode 4 - Stage 4 Metastatic Breast Cancer Outlier Pearl Balgaroo Talks Survival 15 Years Later... 1:00:55

2+ y ago1:00:55

1:00:55

Diagnosed initially in 2006 with metastatic stage 4, PR+ breast cancer and then again in 2020 with triple negative breast cancer, Pearl continues to defy the statistics with focus and tenacity. 15 years after her diagnosis, she is with us to talk survival.By Sarita/Pearl Balgaroo

1
Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma 22:38

2+ y ago22:38

22:38

Interview with Robert J. Motzer, MD, author of Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma. Hosted by Jack West, MD.

1
Fork Cancer! Episode 3 - A Husband Speaks - A Conversation with Curtis Khan 49:12

2+ y ago49:12

49:12

Curtis's wife Alexa, was diagnosed with Stage 4 stomach cancer in 2015, and given, at best, a year to live. Alexa recently passed away, 6 and a half years after her diagnosis. Curtis was her support and self-appointed caregiver, and he shares Alexa's story, as well as his thoughts and feelings both during her journey and after her death.…

1
Fork Cancer! Episode 2 - Stage 3b HER2+ Breast Cancer, a Uniboob, Menopause and Her Fork Cancer Mentality - A Conversation with Sarita Rampersad 43:56

2+ y ago43:56

43:56

Sarita talks with friends about her diagnosis and treatment for Stage 3B Her2+ breast cancer, including coming to terms with her uniboob, menopause and her fork cancer mentality. Websites mentioned in this episode - http://www.saritasaysforkcancer.com http://www.ncbi.nim..nih.gov http://www.pubmed.com http://www.researchgate.net http://www.mskcc.or…

1
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer 23:56

2+ y ago23:56

23:56

Interview with Emmanouil Fokas, MD, DPhil, author of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. Hosted by Jack West, MD.

1
Fork Cancer! Confronting Metastatic Breast Cancer De Novo - a Conversation with Tracy Hutchinson Wallace 58:46

2+ y ago58:46

58:46

Tracy fearlessly and honestly discusses her initial diagnosis with metastatic breast cancer de novo (de novo means being diagnosed with cancer for the first time), talking about navigating her journey while parenting two young boys, living with intention, and planning for her end of life and her sons’ well being. Website mentioned in this episode -…

1
Clinical Outcomes and Toxic Effects of Single-Agent ICI Treatment Among Geriatric Patients With Cancer 21:19

2+ y ago21:19

21:19

Interview with Abdul Rafeh Naqash, MD, and Caroline A. Nebhan, MD, PhD, authors of Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study. Hosted by Jack West, MD.

1
Depression in Patients with Cancer 27:56

2+ y ago27:56

27:56

Presenter: Philip R. Muskin MD, MA, DLFAPA Professor of Psychiatry Columbia University Irving Medical Center Senior Consultant in Consultation-Liaison Psychiatry New York-Presbyterian Hospital New York, NY Chronic medical illnesses such as cancer are characterized by a notably increased prevalence of depression. Furthermore, several challenges may …

1
Optimal Treatment of Metastatic TNBC 29:30

2+ y ago29:30

29:30

Presenter: Hope S. Rugo MD Professor of Medicine University of California San Francisco Comprehensive Cancer Center TNBC comprises approximately 15% of newly diagnosed breast cancer cases and is defined by being estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor receptor 2-negative. This breast cancer subt…

1
Using Available Evidence and Guidelines for Managing an Evolving AML Treatment Paradigm 27:20

3y ago27:20

27:20

Presenter: Gail J. Roboz MD Professor of Medicine Director, Clinical and Translational Leukemia Program Weill Medical College of Cornell University New York-Presbyterian Hospital New York, New York, United States This brief program will begin with a review of NCCN Guidelines® Recommendations for the treatment of AML in individuals 60 years of age o…

1
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer 34:49

3y ago34:49

34:49

Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial

1
Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With NSCLC 16:52

3y ago16:52

16:52

Interview with Puneeth Iyengar, MD, PhD, author of Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non–Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial

1
Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer 16:31

3y ago16:31

16:31

Interview with Carsten Finke, MD, and Frederik Bartels, MD, authors of Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer

1
Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in ERBB2-Positive Breast Cancer 13:01

3y ago13:01

13:01

Interview with Thomas Hatschek, MD, PhD, author of Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial

1
Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases 19:04

3y ago19:04

19:04

Interview with David R. Raleigh, MD, PhD, and William C. Chen, MD, authors of Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases: A Systematic Review and Meta-analysis

1
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC 15:06

3y ago15:06

15:06

Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

1
Chronic Toxic Effects Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma 17:39

3y ago17:39

17:39

Interview with Douglas B. Johnson, MD, author of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma

1
Anti–PD-1 Immunotherapy in Microsatellite-Stable Tumors With 10 or More Mutations per Megabase 29:39

3+ y ago29:39

29:39

Interview with Luc GT Morris, MD MSc, author of Response Rates to Anti–PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase

1
Virtual Care Across a Tertiary Cancer Center During COVID-19 23:45

3+ y ago23:45

23:45

Interview with Alejandro Berlin, MD, MSc, author of Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19

1
Osteonecrosis of the Jaw in Patients Receiving Zoledronic Acid for Bone Metastases 13:00

3+ y ago13:00

13:00

Interview with Catherine Van Poznak, MD, author of Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer

1
Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia 15:19

3+ y ago15:19

15:19

Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial

Podcasts Worth a Listen

Metastatic Tnbc Podcasts

Podcasts Worth a Listen

Quick Reference Guide